Amryt Pharma (AMYT)

Sector:

Financials

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 16.38p
   
  • Change Today:
      0.000p
  • 52 Week High: 25.75
  • 52 Week Low: 16.13
  • Currency: UK Pounds
  • Shares Issued: 274.82m
  • Volume: 89,339
  • Market Cap: 45.00m
  • Beta: 0.00

Amryt Pharma Overview

Amryt Pharma is in the financials sector and is currently trading at 16.38p per share. In the last year Amryt Pharma's share price has ranged from 16.13p to 25.75p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart (22-06-2018)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -111.2% -142.2%
ROCE 171.8%  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 4.0 3.3
Pr/Book 2.3  
Latest F'cast
Revenue 846.7% -5.7%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Amryt Pharma Fundamentals

Year Ending Revenue ( m) Pre-tax ( m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-14 n/a (2.56) (0.87)¢ n/a n/a n/a n/a 0.0%
31-Mar-15 n/a (1.87) (4.32)¢ n/a n/a n/a n/a 0.0%
31-Dec-15 n/a (1.19) (2.84)¢ n/a n/a n/a n/a 0.0%
31-Dec-16 1.35 (7.80) (4.78)¢ n/a n/a n/a n/a 0.0%
31-Dec-17 12.78 (26.14) (11.72)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Amryt Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 13.72 (19.52) (8.61)p n/a n/a n/a n/a 0.0%
31-Dec-19 16.41 (20.21) (7.26)p n/a n/a n/a n/a 0.0%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Amryt Pharma Company Announcements

Result of AGM 05-Jun-2018 10:41 RNS
Exclusive Lojuxta® Licence Expanded 10-May-2018 07:00 RNS
Holding(s) in Company 09-May-2018 14:48 RNS

Latest Amryt Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Amryt Pharma Market Data

Currency UK Pounds
Share Price 16.38p
Change Today 0.000p
% Change 0.00 %
52 Week High 25.75
52 Week Low 16.13
Volume 89,339
Shares Issued 274.82m
Market Cap 45.00m
Beta 0.00

Amryt Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
16.59% below the market average16.59% below the market average16.59% below the market average16.59% below the market average16.59% below the market average
2.13% below the sector average2.13% below the sector average2.13% below the sector average2.13% below the sector average2.13% below the sector average
Price Trend
69.2% below the market average69.2% below the market average69.2% below the market average69.2% below the market average69.2% below the market average
72.55% below the sector average72.55% below the sector average72.55% below the sector average72.55% below the sector average72.55% below the sector average
Income Not Available
Growth
25.09% above the market average25.09% above the market average25.09% above the market average25.09% above the market average25.09% above the market average
25.98% above the sector average25.98% above the sector average25.98% above the sector average25.98% above the sector average25.98% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Amryt Pharma Dividends

No dividends found

Trades for 22-Jun-2018

Time Volume / Share Price
14:09 43,000 @ 16.31p
11:10 25,000 @ 16.30p
09:02 15,167 @ 16.40p
08:02 6,172 @ 16.30p

Amryt Pharma Key Personnel

CEO Joe Wiley
CFO Rory Nealon

Top of Page